BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15354098)

  • 1. Fluorine 18-tagged fluorodeoxyglucose positron emission tomographic scanning to predict lymph node metastasis, invasiveness, or both, in clinical T1 N0 M0 lung adenocarcinoma.
    Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Kobayashi T; Uno K
    J Thorac Cardiovasc Surg; 2004 Sep; 128(3):396-401. PubMed ID: 15354098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histogram analysis of computed tomography numbers of clinical T1 N0 M0 lung adenocarcinoma, with special reference to lymph node metastasis and tumor invasiveness.
    Nomori H; Ohtsuka T; Naruke T; Suemasu K
    J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1584-9. PubMed ID: 14666037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas.
    Okada M; Tauchi S; Iwanaga K; Mimura T; Kitamura Y; Watanabe H; Adachi S; Sakuma T; Ohbayashi C
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1448-54. PubMed ID: 17532938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: A predictor of lymph node metastasis.
    Matsuguma H; Yokoi K; Anraku M; Kondo T; Kamiyama Y; Mori K; Tominaga K; Tsuura Y; Honjo S
    J Thorac Cardiovasc Surg; 2002 Aug; 124(2):278-84. PubMed ID: 12167787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1365-71. PubMed ID: 22883546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [F-18]Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas.
    Watanabe K; Nomori H; Ohtsuka T; Naruke T; Ebihara A; Orikasa H; Yamazaki K; Uno K; Kobayashi T; Goya T
    Jpn J Clin Oncol; 2006 Jul; 36(7):403-9. PubMed ID: 16782729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The maximum standardized 18F-fluorodeoxyglucose uptake on positron emission tomography predicts lymph node metastasis and invasiveness in clinical stage IA non-small cell lung cancer.
    Maeda R; Isowa N; Onuma H; Miura H; Harada T; Touge H; Tokuyasu H; Kawasaki Y
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):79-82. PubMed ID: 19366724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Satellite pulmonary nodule in the same lobe (T4N0) should not be staged as IIIB non-small cell lung cancer.
    Bryant AS; Pereira SJ; Miller DL; Cerfolio RJ
    Ann Thorac Surg; 2006 Nov; 82(5):1808-13; discussion 1813-4. PubMed ID: 17062253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The maximum standardized uptake values on positron emission tomography to predict the Noguchi classification and invasiveness in clinical stage IA adenocarcinoma measuring 2 cm or less in size.
    Maeda R; Isowa N; Onuma H; Miura H; Harada T; Touge H; Tokuyasu H; Kawasaki Y
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):70-3. PubMed ID: 19359282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [False negative cases of F-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging in small lung cancer less than 3 cm in size].
    Watanabe K; Nomori H; Ohtsuka T; Naruke T; Uno K
    Nihon Kokyuki Gakkai Zasshi; 2004 Sep; 42(9):787-93. PubMed ID: 15500145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted magnetic resonance imaging in preoperative assessment of non-small cell lung cancer.
    Nomori H; Cong Y; Abe M; Sugimura H; Kato Y
    J Thorac Cardiovasc Surg; 2015 Apr; 149(4):991-6. PubMed ID: 25686657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis and histologic features of small pulmonary adenocarcinoma based on serum carcinoembryonic antigen level and computed tomographic findings.
    Takamochi K; Yoshida J; Nishimura M; Yokose T; Sasaki S; Nishiwaki Y; Suzuki K; Nagai K
    Eur J Cardiothorac Surg; 2004 May; 25(5):877-83. PubMed ID: 15082298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative 18F-fluorodeoxyglucose positron emission tomography can predict the tumor malignancy of small peripheral lung cancer.
    Kosaka T; Yamaki E; Tanaka S; Mogi A; Kuwano H
    Ann Thorac Cardiovasc Surg; 2014; 20(6):968-73. PubMed ID: 24284507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic Factors Associated With Occult Lymph Node Metastasis in Patients With Clinically Diagnosed N0 Lung Adenocarcinoma.
    Moon Y; Kim KS; Lee KY; Sung SW; Kim YK; Park JK
    Ann Thorac Surg; 2016 May; 101(5):1928-35. PubMed ID: 26952299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypes.
    Mimae T; Miyata Y; Mimura T; Ito H; Nakayama H; Okumura S; Yoshimura M; Okada M
    Jpn J Clin Oncol; 2015 Aug; 45(8):767-73. PubMed ID: 26056324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study.
    Higashi K; Ito K; Hiramatsu Y; Ishikawa T; Sakuma T; Matsunari I; Kuga G; Miura K; Higuchi T; Tonami H; Yamamoto I
    J Nucl Med; 2005 Feb; 46(2):267-73. PubMed ID: 15695786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathologic characterization of lung adenocarcinoma in relation to fluorine-18-fluorodeoxyglucose uptake on positron emission tomography.
    Domen H; Hida Y; Okamoto S; Hatanaka KC; Hatanaka Y; Kaga K; Tamaki N; Hirano S; Matsuno Y
    Jpn J Clin Oncol; 2013 Sep; 43(9):874-82. PubMed ID: 23911772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):607-12. PubMed ID: 22104678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ratio of the maximum high attenuation area dimension to the maximum tumor dimension may be an index of the presence of lymph node metastasis in lung adenocarcinomas 3 cm or smaller on high-resolution computed tomography.
    Nishio R; Akata S; Saito K; Ohira T; Tsuboi M; Hirano T; Ikeda N; Kotake F; Kato H; Abe K
    J Thorac Oncol; 2007 Jan; 2(1):29-33. PubMed ID: 17410006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.